New Indication: Trelegy Ellipta

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Lyme disease rates diagnosis

    Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Medicare indirect billing

    Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

Trelegy Ellipta is now approved for the maintenance treatment of asthma in patients aged 18 years and older.

Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.

This article originally appeared on MPR

Next hm-slideshow in Uncategorized